UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent

PloS one, 2012-05, Vol.7 (5), p.e35981-e35981

2012

Volltextzugriff (PDF)

Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21

Journal for immunotherapy of cancer, 2019-07, Vol.7 (1), p.164-164, Article 164

2019

Volltextzugriff (PDF)

Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells

Molecular therapy. Oncolytics, 2023-06, Vol.29, p.17-29

2023

Volltextzugriff (PDF)

Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche

Journal for immunotherapy of cancer, 2021-03, Vol.9 (3), p.e001803

2021

Volltextzugriff (PDF)

UCH‐L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease

Journal of neurochemistry, 2004-07, Vol.90 (2), p.379-391

2004

Volltextzugriff (PDF)

Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing

Biochemical journal, 2010-11, Vol.431 (3), p.423-431

2010

Volltextzugriff (PDF)

Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition

Molecular therapy, 2019-06, Vol.27 (6), p.1139-1152

2019

Volltextzugriff (PDF)

Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin

Molecular biology of the cell, 2003-11, Vol.14 (11), p.4541-4556

2003

Volltextzugriff (PDF)

Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapy

Cellular immunology, 2015-09, Vol.297 (1), p.1-9

2015

Volltextzugriff (PDF)

Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients

BMC medical genetics, 2011-06, Vol.12 (1), p.84-84, Article 84

2011

Volltextzugriff (PDF)

Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes

Molecular immunology, 2014-04, Vol.58 (2), p.160-168

2014

Volltextzugriff (PDF)

Epithelial cell ADAM17 activation by Helicobacter pylori: role of ADAM17 C-terminus and Threonine-735 phosphorylation

Microbes and infection, 2015-03, Vol.17 (3), p.205-214

2015

Volltextzugriff (PDF)

Detecting variable (V), diversity (D) and joining (J) gene segment recombination using a two-colour fluorescence system

Mobile DNA, 2010-03, Vol.1 (1), p.9-9, Article 9

2010

Volltextzugriff (PDF)

Effect of combined dexamethasone/lenalidomide therapy on NK cell–receptor levels in myeloma patients

Blood, 2011-12, Vol.118 (24), p.6465-6466

2011

Volltextzugriff (PDF)

In vitro functional effects of XPC gene rare variants from bladder cancer patients

Carcinogenesis (New York), 2011-04, Vol.32 (4), p.516-521

2011

Volltextzugriff (PDF)

Human homologue of ariadne promotes the ubiquitylation of translation initiation factor 4E homologous protein, 4EHP

FEBS letters, 2003-11, Vol.554 (3), p.501-504

2003

Volltextzugriff (PDF)

Potassium diazoacetate-induced p53 mutations in vitro in relation to formation of O6-carboxymethyl- and O6-methyl-2′-deoxyguanosine DNA adducts: relevance for gastrointestinal cancer

Carcinogenesis (New York), 2007-02, Vol.28 (2), p.356-362

2007

Volltextzugriff (PDF)

Th17 Cells Are Increased in the Bone Marrow but Not the Peripheral Blood in Multiple Myeloma and Demonstrate Defective Functionality and Aberrant Phenotypes

Blood, 2014-12, Vol.124 (21), p.3420-3420

2014

Volltextzugriff (PDF)

Abstract 20: Oncolytic virotherapy enhances Smac mimetic treatment of acute myeloid leukemia

Clinical cancer research, 2017-12, Vol.23 (24_Supplement), p.20-20

2017

Volltextzugriff (PDF)

Abstract 18: Evaluating the contribution of anti-myeloma immunity for the efficacy of oncolytic reovirus therapy

Clinical cancer research, 2017-12, Vol.23 (24_Supplement), p.18-18

2017

Volltextzugriff (PDF)

Combination Therapy with Reovirus and Immunomodulatory Drugs Induces Direct Oncolytic and Immune-Mediated Killing of Multiple Myeloma Cells and Overcomes Stromal-Mediated Microenvironmental Protection

Blood, 2014-12, Vol.124 (21), p.4778-4778

2014

Volltextzugriff (PDF)

Lenalidomide Redresses the Effector T Cell:Treg Cell Imbalance in Patients with Multiple Myeloma

Blood, 2012-11, Vol.120 (21), p.2977-2977

2012

Volltextzugriff (PDF)

Immune Dysfunction in Multiple Myeloma

International journal of hematologic oncology, 2013-02, Vol.2 (1), p.49-59

2013

Volltextzugriff (PDF)

Profiling killers; unravelling the pathways of human natural killer cell function

Briefings in functional genomics & proteomics, 2008-01, Vol.7 (1), p.8-16

2008

Volltextzugriff (PDF)

Detecting variable gene segment recombination using a two-colour fluorescence system

Mobile DNA, 2010-03, Vol.1, p.9

2010

Volltextzugriff (PDF)

1 – 25 von 235

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(219)
Mit Volltextzugriff
(180)

Publikationsform

Sprache

Englisch
(235)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent

Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21

Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells

Reovirus-induced cell-mediated immunity for the treatment of multiple myeloma within the resistant bone marrow niche

UCH‐L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease

Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing

Potentiating Oncolytic Virus-Induced Immune-Mediated Tumor Cell Killing Using Histone Deacetylase Inhibition

Inhibition of proteasomal activity causes inclusion formation in neuronal and non-neuronal cells overexpressing Parkin

Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapy

Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients

Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes

Epithelial cell ADAM17 activation by Helicobacter pylori: role of ADAM17 C-terminus and Threonine-735 phosphorylation

Detecting variable (V), diversity (D) and joining (J) gene segment recombination using a two-colour fluorescence system

Effect of combined dexamethasone/lenalidomide therapy on NK cell–receptor levels in myeloma patients

In vitro functional effects of XPC gene rare variants from bladder cancer patients

Human homologue of ariadne promotes the ubiquitylation of translation initiation factor 4E homologous protein, 4EHP

Potassium diazoacetate-induced p53 mutations in vitro in relation to formation of O6-carboxymethyl- and O6-methyl-2′-deoxyguanosine DNA adducts: relevance for gastrointestinal cancer

Th17 Cells Are Increased in the Bone Marrow but Not the Peripheral Blood in Multiple Myeloma and Demonstrate Defective Functionality and Aberrant Phenotypes

Abstract 20: Oncolytic virotherapy enhances Smac mimetic treatment of acute myeloid leukemia

Abstract 18: Evaluating the contribution of anti-myeloma immunity for the efficacy of oncolytic reovirus therapy

Combination Therapy with Reovirus and Immunomodulatory Drugs Induces Direct Oncolytic and Immune-Mediated Killing of Multiple Myeloma Cells and Overcomes Stromal-Mediated Microenvironmental Protection

Lenalidomide Redresses the Effector T Cell:Treg Cell Imbalance in Patients with Multiple Myeloma

Immune Dysfunction in Multiple Myeloma

Profiling killers; unravelling the pathways of human natural killer cell function

Detecting variable gene segment recombination using a two-colour fluorescence system

Suchergebnisse filtern